Major complications of post-chemotherapy retroperitoneal lymph node dissection in a contemporary cohort of patients with testicular cancer and a review of the literature
- PMID: 32972425
- PMCID: PMC7517823
- DOI: 10.1186/s12957-020-02032-1
Major complications of post-chemotherapy retroperitoneal lymph node dissection in a contemporary cohort of patients with testicular cancer and a review of the literature
Abstract
Background: Post-chemotherapy retroperitoneal lymph node dissection (pc-RPLND) is one cornerstone in the clinical management of patients with nonseminomatous testicular germ cell tumours (GCT). A wide range of complication rates in this type of surgery is reported so far. We retrospectively evaluated the frequency of major complications by using the Clavien-Dindo classification and analysed the influence of various clinical factors on complication rates in pc-RPLND.
Methods: We retrospectively analysed 146 GCT patients undergoing pc-RPLND. Complications of grade III-V according to the Clavien-Dindo classification occurring within 30 days after surgery were registered along with the following clinical factors: age, body mass index (BMI), duration of surgery, number of anatomic fields resected, side of primary tumour, histology of surgical specimen, histology of primary tumour, and total dose of cisplatin applied prior to surgery. For comparison, we also evaluated 35 chemotherapy-naïve patients with primary RPLND and 19 with laparoscopic RPLND. We analysed types and frequencies of the various complications as well as associations with clinical factors using descriptive statistical methods.
Results: A total of 14.4% grade III-IV complications were observed in pc-RPLND, and 8.6% and 5.3% in primary and in laparoscopic RPLND, respectively. There was no perioperative mortality. Lymphocele was the most frequent adverse event (16% of grade III-IV complications). Operation time > 270 min (p = 0.001) and vital cancer in the resected specimen (p = 0.02) were significantly associated with higher complication rates. Left-sided resection fields involved two-fold higher complication rates, barely missing statistical significance (p = 0.06).
Conclusions: Pc-RPLND involves a grade III-V complication rate of 14.4%. Prolonged operation time and vital cancer in the residual mass are significantly associated with higher complication rates. The Clavien-Dindo classification system may allow inter-observer variation in rating complication grades, which may represent one reason for the wide range of reported RPLND complication rates. RPLND represents major surgery and surgeons active in this field must be competent to manage adverse events.
Keywords: Lymphocele; Nonseminoma; Retroperitoneal lymph node dissection; Surgical complication; Testicular germ cell tumour.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Comment in
-
Urological Oncology: Testis Cancer and Advances in Oncologic Therapy.J Urol. 2022 May;207(5):1157. doi: 10.1097/JU.0000000000002478. Epub 2022 Feb 14. J Urol. 2022. PMID: 35152711 No abstract available.
Similar articles
-
Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group.Eur Urol Oncol. 2020 Jun;3(3):382-389. doi: 10.1016/j.euo.2019.08.002. Epub 2019 Sep 8. Eur Urol Oncol. 2020. PMID: 31506250
-
Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.J Endourol. 2016 Oct;30(10):1112-1119. doi: 10.1089/end.2016.0458. J Endourol. 2016. PMID: 27533924
-
Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.Eur Urol. 2017 Nov;72(5):814-820. doi: 10.1016/j.eururo.2017.02.024. Epub 2017 Mar 18. Eur Urol. 2017. PMID: 28325537
-
Perioperative morbidity of open retroperitoneal lymph node dissection for testicular germ cell tumors: an in-depth single center analysis according to European Association of Urology guidelines of complication reporting and a scoping literature review.Surg Oncol. 2025 Jun;60:102228. doi: 10.1016/j.suronc.2025.102228. Epub 2025 May 9. Surg Oncol. 2025. PMID: 40378498
-
Clinical outcome of post-chemotherapy retroperitoneal lymph node dissection in metastatic nonseminomatous germ cell tumour: A systematic review.Eur J Surg Oncol. 2020 Jun;46(6):999-1005. doi: 10.1016/j.ejso.2020.02.035. Epub 2020 Feb 26. Eur J Surg Oncol. 2020. PMID: 32173176
Cited by
-
The Role of CT in the Staging and Follow-Up of Testicular Tumors: Baseline, Recurrence and Pitfalls.Cancers (Basel). 2022 Aug 17;14(16):3965. doi: 10.3390/cancers14163965. Cancers (Basel). 2022. PMID: 36010958 Free PMC article. Review.
-
Robotic Retroperitoneal Lymph Node Dissection for Testicular Cancer-First Experience and Learning Curve of a Single Surgeon.Cancers (Basel). 2025 Apr 27;17(9):1476. doi: 10.3390/cancers17091476. Cancers (Basel). 2025. PMID: 40361402 Free PMC article.
-
Lymph Node Dissection in Testicular Cancer: The State of the Art and Future Perspectives.Curr Oncol Rep. 2024 Apr;26(4):318-335. doi: 10.1007/s11912-024-01511-y. Epub 2024 Mar 2. Curr Oncol Rep. 2024. PMID: 38430323 Free PMC article. Review.
-
Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience.Eur Urol Open Sci. 2024 Jun 11;65:13-19. doi: 10.1016/j.euros.2024.05.006. eCollection 2024 Jul. Eur Urol Open Sci. 2024. PMID: 38966804 Free PMC article.
-
Radiomics Analyses to Predict Histopathology in Patients with Metastatic Testicular Germ Cell Tumors before Post-Chemotherapy Retroperitoneal Lymph Node Dissection.J Imaging. 2023 Oct 7;9(10):213. doi: 10.3390/jimaging9100213. J Imaging. 2023. PMID: 37888320 Free PMC article.
References
-
- Kocher T. Die Krankheiten der männlichen Geschlechtsorgane. Stuttgart: Ferdinand Enke Verlag; 1887. §1006; pp. 491–492.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical